Flavone Derivatives Targeting CK2 for Neuroinflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's are inadequate in addressing chronic inflammation and mitochondrial dysfunction, which are driven by elevated Casein Kinase 2 (CK2) activity, leading to neurotoxicity and neuronal death.
Innovation Solution
Development of flavone derivatives that inhibit CK2 enzyme activity, specifically targeting astrocytes and microglia to reduce phosphorylation of biomarkers, increase mitophagy, and enhance mitochondrial function, thereby mitigating neuroinflammatory responses and mitochondrial defects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for neurodegenerative diseases are used, then existing therapeutic options are available, but they fail to address chronic inflammation and mitochondrial dysfunction driven by elevated CK2 activity
Solution Approach 1:
The patent applies parameter changes by developing flavone derivatives with specific chemical structures (Formula I) that modify the pharmacological parameters of CK2 inhibition. The compounds are designed to achieve optimal binding affinity and selectivity for CK2, thereby improving therapeutic efficacy specifically针对 CK2-mediated inflammation and mitochondrial dysfunction in neurodegenerative diseases
2Object-affected harmful factors
If CK2 activity is not inhibited, then existing treatments maintain simplicity, but neuroinflammation and mitochondrial defects persist leading to neurotoxicity
Solution Approach 1:
The patent extracts and targets the specific pathological mechanism of CK2-mediated neuroinflammation and mitochondrial dysfunction. By designing flavone derivatives that specifically inhibit CK2, the treatment isolates and addresses the key harmful pathway without requiring complex multi-target approaches, thereby reducing treatment complexity while effectively combating neuroinflammation
3Reliability
If flavone derivatives are developed to target CK2, then specific inhibition of CK2-mediated pathways is achieved, but development and characterization complexity increases
Solution Approach 1:
The patent employs universality by designing flavone derivatives with a core structural framework (Formula I) that provides multi-functional activity. The compounds simultaneously achieve CK2 inhibition, anti-inflammatory effects, and mitochondrial protection through their versatile chemical structure, reducing the need for separate targeted therapies while maintaining high specificity for CK2-mediated pathways
Data Source
AI summary
Flavone derivatives and pharmaceutical compositions including the derivatives are disclosed. In some instances, the compounds have increased aqueous solubility, bioavailability, and ability to cross the blood-brain-barrier. The compounds may be used to inhibit CK2 activity and/or to treat diseases and conditions mediated at least in part by CK2 enzyme.